KEQU EBITDA Margin	(Apr 30 2025) Q4	(Jan 31 2025) Q3	(Oct 31 2024) Q2	(Jul 31 2024) Q1	(Apr 30 2024) Q4
Y / Y Revenue Change	34.79 %	44.21 %	-5.09 %	-2.92 %	8.62 %
Seq. Revenue Change	19.07 %	41.38 %	-1.13 %	-19.02 %	27.4 %
Revenue In Millions	$79.04	$66.38	$46.95	$47.49	$58.64
EBITDA Margin	13.91 %	5.99 %	11.03 %	7.83 %	4.69 %
EBITDA Margin Total Ranking	# 1612	# 2331	# 1981	# 2291	# 2537
EBITDA In Millions	$10.99	$3.98	$5.18	$3.72	$2.75
Y / Y EBITDA Change	299.31 %	-16.19 %	-13.5 %	-18.49 %	-23.34 %
Seq. EBITDA Change	176.55 %	-23.25 %	39.33 %	35.02 %	-41.96 %

New: More KEQU's historic EBITDA Margin results >>

Commenting fourth quarter 2025 EBITDA Margin

Kewaunee Scientific Corporation EBITDA grew by 176.55 % in Q4 sequentially to 11 millions, while Revenue increased by 19.07 %, this led to improvement in the company's EBITDA Margin to 13.91 % a new company high.

Observing fourth quarter 2025 results within Laboratory Analytical Instruments industry 8 other companies have achieved higher EBITDA Margin. While EBITDA Margin total ranking has impoved so far to 1612, from total ranking in the previous quarter at 2331.
Learn about Operating Margin

KEQU's EBITDA Margin fourth quarter 2025 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 9
Healthcare Sector	# 137
Overall	# 1612

EBITDA Margin Statistics
High	Average	Low
13.91 %	6.38 %	0.14 %
(Apr 30 2025)		(Jan 31 2021)

KEQU Ebit Trends • Compare KEQU's Earnings before interest, taxes, depreciation and amortization margin • KEQU Income Statement

Other EBITDA Margin Profitability Ratios
KEQU's Cumulative EBITDA Margin
Laboratory Analytical Instruments Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
KEQU's EBITDA Margin Profitability versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for KEQU's Competitors
EBITDA Margin Profit Margin for Kewaunee Scientific's Suppliers
EBITDA Margin Profit Margin for KEQU's Customers

You may also want to know
KEQU's Annual Growth Rates	KEQU's Profitability Ratios	KEQU's Asset Turnover Ratio	KEQU's Dividend Growth
KEQU's Roe	KEQU's Valuation Ratios	KEQU's Financial Strength Ratios	KEQU's EBITDA Growth
KEQU's Roa	KEQU's Inventory Turnover Ratio	KEQU's Growth Rates	KEQU's Dividend Comparisons

Companies with similar EBITDA Margin in the quarter ending Apr 30 2025, within Laboratory Analytical Instruments Industry	EBITDA Margin	Apr 30 2025 MRQ EBITDA	Apr 30 2025 MRQ Revenue
Waters Corporation	31.21 %	$ 206.527 Millions	$ 661.705 Millions
Mettler Toledo International Inc	26.15 %	$ 231.059 Millions	$ 883.744 Millions
Illumina Inc	24.11 %	$ 251.000 Millions	$ 1,041.000 Millions
Revvity Inc	22.70 %	$ 150.906 Millions	$ 664.762 Millions
Agilent Technologies inc	21.70 %	$ 362.000 Millions	$ 1,668.000 Millions
Rapid Micro Biosystems Inc	18.22 %	$ 1.313 Millions	$ 7.205 Millions
Bio rad Laboratories Inc	16.31 %	$ 95.400 Millions	$ 585.000 Millions
Avantor Inc	14.53 %	$ 229.800 Millions	$ 1,581.400 Millions
Kewaunee Scientific Corporation	13.91 %	$ 10.993 Millions	$ 79.038 Millions
Bruker Corporation	9.42 %	$ 75.500 Millions	$ 801.200 Millions

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com